Published 1 year ago

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Summary by Ground News

Cardiosense, Inc. has raised $15.1 million in Series A funding. The capital will be used to support team expansion, accelerate product development, and fund an expansive heart failure study. The Company's first clinical application focuses on improving the management of congestive heart failure (CHF)

0 Articles

All

Left

Center

Right

PR Newswire

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection...

1 year ago·United States

Read Full Article

AiThority

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices

1 year ago

Read Full Article

labpulse.com

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

The Chicago-based digital health company is leveraging artificial intelligence and multisensor devices to develop tools that enable the early detection of cardiovascular disease.

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated1 year agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

0 Articles

0 Articles

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics